Voloridge Investment Management, LLC Axsome Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $6.39 Million - $12.8 Million	-160,113 Reduced 74.89%	53,680 $4.14 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $3.66 Million - $7.08 Million	101,384 Added 90.19%	213,793 $9.54 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $2.24 Million - $4.81 Million	-102,810 Reduced 47.77%	112,409 $4.31 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $684,787 - $1.2 Million	28,894 Added 15.51%	215,219 $8.91 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $2.8 Million - $3.96 Million	-91,315 Reduced 32.89%	186,325 $7.04 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $5.53 Million - $19 Million	277,640 New	277,640 $9.15 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $659,202 - $956,970	-13,020 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $727,948 - $1.06 Million	13,020 New	13,020 $737,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $363,302 - $718,956	-7,285 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $300,142 - $738,043	7,285 New	7,285 $429,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.